MedTrace Logo

Glycemic Control and Diabetic Macular Edema

NCT01358396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2011-05-23

No results posted yet for this study

Summary

Does diabetic patients' glycemic control affect their response to laser and/or intravitreal injection therapy in terms of visual and anatomical outcomes.

Conditions

Interventions

OTHER

Respond to therapy for diabetic macular edema

Correlate HBA1c with visual acuity outcome to therapy.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-07-31
Completion
2010-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01358396 on ClinicalTrials.gov